Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

溃疡性结肠炎 医学 胃肠病学 重症监护医学 内科学 疾病
作者
Axel Dignaß,Rami Eliakim,Fernando Magro,Christian Maaser,Yehuda Chowers,Karel Geboes,Gerassimos J. Mantzaris,Walter Reinisch,Jean–Frédéric Colombel,Séverine Vermeire,Simon Travis,James O. Lindsay,Gert Van Assche
出处
期刊:Journal of Crohn's and Colitis [Oxford University Press]
卷期号:6 (10): 965-990 被引量:846
标识
DOI:10.1016/j.crohns.2012.09.003
摘要

### 1.1 Introduction Ulcerative colitis is a lifelong disease arising from an interaction between genetic and environmental factors, observed predominantly in the developed countries of the world. The precise aetiology is unknown and therefore medical therapy to cure the disease is not yet available. Within Europe there is a North–South gradient, but the incidence appears to have increased in Southern and Eastern countries in recent years.1,2 Patients may live with a considerable symptom burden despite medical treatment (66% describe interference with work and 73% with leisure activities3) in the hope that the aetiology of ulcerative colitis will shortly be revealed and a cure emerge. Although this is conceivable in the next decade, clinicians have to advise patients on the basis of information available today. Despite randomised trials there will always be many questions that can only be answered by the exercise of judgement and opinion. This leads to differences in practice between clinicians, which may be brought into sharp relief by differences in emphasis between countries. This Consensus endeavours to address these differences. The Consensus is not meant to supersede the guidelines of different countries (such as those from the UK,4 or Germany,5) which reach broadly the same conclusions since they are, after all, based on the same evidence. Rather, the aim of the Consensus is to promote a European perspective on the management of ulcerative colitis (UC) and its dilemmas. Since the development of guidelines is an expensive and time-consuming process, it may help to avoid duplication of effort in the future. A European Consensus is also considered important because an increasing number of therapeutic trials recruit from Central and Eastern European countries where practice guidelines have yet to be published. This document updates the previous European Consensus on the diagnosis and management of UC, and …

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sa0022完成签到,获得积分10
刚刚
飞快的冰淇淋完成签到 ,获得积分10
2秒前
3秒前
RRR232完成签到 ,获得积分10
3秒前
魔幻的莫茗完成签到 ,获得积分10
3秒前
OYYO完成签到,获得积分10
4秒前
现实的日记本完成签到,获得积分10
5秒前
拼搏的萧完成签到 ,获得积分10
6秒前
刘亮亮完成签到,获得积分10
8秒前
默默莫莫完成签到 ,获得积分10
9秒前
chen完成签到,获得积分10
9秒前
9秒前
听话的醉冬完成签到 ,获得积分10
10秒前
kyt完成签到 ,获得积分10
10秒前
江江完成签到 ,获得积分10
12秒前
然而。完成签到 ,获得积分10
12秒前
倪小呆完成签到 ,获得积分10
12秒前
量子星尘发布了新的文献求助10
13秒前
lorentzh完成签到,获得积分10
14秒前
熊猫完成签到 ,获得积分10
16秒前
fys2022完成签到,获得积分10
17秒前
包容明辉完成签到 ,获得积分10
17秒前
dongtan完成签到 ,获得积分10
19秒前
幽默的迎天完成签到,获得积分10
19秒前
20秒前
猛龙FC20完成签到,获得积分10
23秒前
明明千岁千岁千千岁完成签到 ,获得积分10
23秒前
HtObama完成签到,获得积分10
24秒前
一枝完成签到 ,获得积分10
25秒前
愉快的冉阿让完成签到,获得积分10
25秒前
yy完成签到,获得积分10
25秒前
1_1完成签到,获得积分10
27秒前
明理冷梅完成签到 ,获得积分10
28秒前
希望天下0贩的0应助洋酱采纳,获得10
28秒前
yjx完成签到 ,获得积分10
30秒前
量子星尘发布了新的文献求助10
31秒前
32秒前
32秒前
滕青寒完成签到,获得积分10
32秒前
aweiei完成签到 ,获得积分10
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Social Work and Social Welfare: An Invitation(7th Edition) 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6059150
求助须知:如何正确求助?哪些是违规求助? 7891721
关于积分的说明 16297249
捐赠科研通 5203429
什么是DOI,文献DOI怎么找? 2783957
邀请新用户注册赠送积分活动 1766631
关于科研通互助平台的介绍 1647154